A Study to Evaluate Lymphoma Epidemiology


NCT ID: NCT04996706
Sponsor Protocol Number: 21-001804

About this study

The purpose of this study is to build a large and diverse observational cohort to support broad and cutting-edge research focused on non-Hodgkin lymphoma (NHL) prognosis and survivorship. 



Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients must be newly diagnosed within 6 months (180 days) of enrollment.
  • Patients may have been treated as long as initial non-Hodgkins Lymphoma (NHL) or Hodgkin's Lymphoma (HL) diagnosis is within 6 months of enrollment.
  • Patients must be 18 years or older.
  • Patients will be recruited regardless of human immunodeficiency virus (HIV) status.

Exclusion Criteria:

  • Patients less than 18 years of age.

More information


Publications are currently not available

Mayo Clinic Footer